Literature DB >> 9509291

Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease.

A Ikeda1, K Nishimura, T Izumi.   

Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD) are usually treated with bronchodilator therapy, glucocorticoids and antibiotics. However, there are few experimental data on the effects of these agents in patients with acute COPD. A beta(2)-adrenoceptor agonist is usually given first because it can be expected to produce a rapid response. An anticholinergic agent should also be given when the patient is severely ill or responds inadequately to the beta(2) agonist. These agents can be administered via a nebuliser or using a metered-dose inhaler in conjunction with a spacer device. Glucocorticoids can accelerate recovery if the standard empirical regimens for acute exacerbations of asthma are used, although a longer treatment duration appears to be required. Theophylline provides little additional benefit in patients who receive frequent doses of inhaled bronchodilators and an adequate dosage of a glucocorticoid. Although the role of bacterial infections is not completely understood, the use of antibiotics is justified in patients with severe airflow limitation who have febrile tracheobronchitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9509291     DOI: 10.2165/00002512-199812020-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  65 in total

Review 1.  Acute exacerbations of COPD. How to evaluate severity and treat the underlying cause.

Authors:  S D Hagedorn
Journal:  Postgrad Med       Date:  1992-01       Impact factor: 3.840

2.  Pharmacokinetics of theophylline in ten elderly patients.

Authors:  F Nielsen-Kudsk; I Magnussen; P Jakobsen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-03

3.  Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis.

Authors:  H Poppius; Y Salorinne
Journal:  Br Med J       Date:  1973-10-20

4.  Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.

Authors:  E Monsó; J Ruiz; A Rosell; J Manterola; J Fiz; J Morera; V Ausina
Journal:  Am J Respir Crit Care Med       Date:  1995-10       Impact factor: 21.405

5.  Bronchodilatation and the site of airway resistance in severe chronic bronchitis.

Authors:  N J Douglas; I Davidson; M F Sudlow; D C Flenley
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

6.  Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis.

Authors:  C P van Schayck; H Folgering; H Harbers; K L Maas; C van Weel
Journal:  Thorax       Date:  1991-05       Impact factor: 9.139

7.  COPD in the elderly. A reversible cause of functional impairment.

Authors:  J T Chang; M B Moran; D W Cugell; J R Webster
Journal:  Chest       Date:  1995-09       Impact factor: 9.410

8.  A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.

Authors:  S R Braun; W N McKenzie; C Copeland; L Knight; M Ellersieck
Journal:  Arch Intern Med       Date:  1989-03

9.  Anti-inflammatory effects of low-dose oral theophylline in atopic asthma.

Authors:  P Sullivan; S Bekir; Z Jaffar; C Page; P Jeffery; J Costello
Journal:  Lancet       Date:  1994-04-23       Impact factor: 79.321

10.  Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency.

Authors:  R K Albert; T R Martin; S W Lewis
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

View more
  5 in total

1.  Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic charge.

Authors:  E Dompeling; A M Oudesluys-Murphy; H M Janssens; W Hop; J G Brinkman; R N Sukhai; J C de Jongste
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

Review 2.  Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease.

Authors:  M Cazzola; C F Donner; M G Matera
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

3.  Intravenous and oral antibiotics in respiratory tract infection: an international observational study of hospital practice.

Authors:  J Cooke; M Kubin; T Morris; J Ribas; I Krämer; W Kämmerer; R Fornaini; A C Ballet; P P Sagnier
Journal:  Pharm World Sci       Date:  2002-12

Review 4.  Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues.

Authors:  Miranda R Andrus; Joyce V Loyed
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 5.  Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  D C McCrory; C D Brown
Journal:  Cochrane Database Syst Rev       Date:  2002
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.